Assert-IQ Insertable Cardiac Monitor Post Market Study
Assert-IQ Insertable Cardiac Monitor Post Market Study
This is a prospective, non-randomized, multi-center, real-world post-market study to collect and evaluate data regarding the performance of the enhanced atrial fibrillation detection algorithm of the Assert-IQTM Implantable Cardiac Monitor (ICM) device.
The study's intent is to generate long-term real-world data on the safety, performance, and clinical benefits of the Assert-IQTM ICM device system. This clinical investigation is sponsored by Abbott Medical.
Inclusion Criteria:
Patients must meet ALL study inclusion criteria to participate in the study.
Exclusion Criteria:
If ANY study exclusion criteria are met, the patient is excluded from the study and cannot be enrolled (recruitment failure).
San Diego, California 92103, United States